Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Abbott Laboratories, a US-based healthcare company, focuses on developing pioneering medical devices, diagnostics, innovative nutrition products, and high-quality pharmaceuticals. The company enhances patient health and quality of life globally through scientific advancements and comprehensive solutions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Abbott Laboratories (ABT) reported its Q2 2026 financial results on July 16, 2026, before the market open. The company reported earnings per share (EPS) of 1.31 USD, beating the analyst estimate of 1.28 USD by 2.6%. Revenue for the quarter reached 12593 million USD. Following the announcement, the stock price rose by 10.71%.
Generated automatically from our data — as of 07/23/2026 Read the article →
Abbott Laboratories is scheduled to report its next quarterly earnings on 10/21/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Abbott Laboratories last reported quarterly earnings on 7/16/2026 (Q2 2026). Earnings per share (EPS) came in at 1.31 USD.
Across its last 5 earnings reports, Abbott Laboratories stock moved by ±6.1% on average the following day. The largest reaction was +10.7% on 07/16/2026; 2 of 5 reactions were positive.
Abbott Laboratories has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.